Overexpression of the human glucocorticoid receptor α and β isoforms inhibits AP-1 and NF-κB activities hormone independently

被引:49
|
作者
Gougat, C
Jaffuel, D
Gagliardo, R
Henriquet, C
Bousquet, J
Demoly, P
Mathieu, M [1 ]
机构
[1] Inst Natl Sante& Rech Med, U454, IFR3, F-34295 Montpellier 5, France
[2] CHU Montpellier, Serv Malad Resp, F-34295 Montpellier, France
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2002年 / 80卷 / 05期
关键词
glucocorticoid receptor; isoforms; activator protein-1; nuclear factor-kappa B; inflammation;
D O I
10.1007/s00109-001-0302-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The human glucocorticoid receptor isoforms GRalpha and GRbeta are generated by alternative splicing. Upon hormone binding, GRalpha regulates positively or negatively transcription. In particular, it represses numerous genes encoding pro-inflammatory mediators by inhibiting the transcription factors activator protein (AP)-1 and nuclear factor (NF)-kappaB. The observation that GRbeta, which does not bind the hormone, may act as a dominant negative receptor is subject to controversy. Because GRbeta must be more abundant than GRalpha to act as such, we evaluated the relative amounts of GRalpha. and GRbeta in COS-1, A549 and HeLa cells using a monoclonal antibody that recognises the two isoforms equally well on western blots. Messenger RNA levels of GRalpha and GRbeta were compared by reverse transcriptase polymerase chain reaction analysis. To gain insight into the possible function of GRbeta, we examined the ability of overexpressed GRbeta to alter transcription of glucocorticoid, AP-1 and NF-kappaB inducible reporter genes using transient transfection in COS-I and A549 cells. Subcellular localisation of GRbeta was determined in A549 cells by immunofluoresence microscopy. Data indicate that GRalpha is the predominant endogenous isoform, in A549 and HeLa cells. GRbeta became the major form after transfection with the corresponding expression vector and translocated into cell nuclei even in the absence of hormone. Overexpression of GRbeta inhibited glucocorticoid-induced transcription markedly in COS-1 cells but weakly in A549 cells. We found that GRbeta did not act as a dominant negative modulator of GRalpha for repression of AP-1 and NF-kappaB activities. In fact, both GRbeta and GRalpha inhibited hormone-independently these activities by 25-60%. This property was not shared by the closely related mineralocorticoid receptor. Our results suggest that overexpression of either GRalpha or GRbeta may have an anti-inflammatory effect.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 50 条
  • [31] Interaction of AP-1 with a cluster of NF-κB binding elements in the human TNF promoter region
    Udalova, IA
    Kwiatkowski, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (01) : 25 - 33
  • [32] Lymphotoxin β receptor induces interleukin 8 gene expression via NF-κB and AP-1 activation
    Chang, YH
    Hsieh, SL
    Chen, MC
    Lin, WW
    EXPERIMENTAL CELL RESEARCH, 2002, 278 (02) : 166 - 174
  • [33] Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways
    Fiebich, Bernd L.
    Collado, Juan A.
    Stratz, Cristian
    Valina, Christian
    Hochholzer, Willibald
    Munoz, Eduardo
    Bellido, Luz M.
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2012, 34 (01) : 98 - 106
  • [34] 4-hydroxykobusin inhibits the induction of nitric oxide synthase by inhibiting NF-κB and AP-1 activation
    Pokharel, Yuba Raj
    Liu, Qing-He
    Oh, Jae Wook
    Woo, Eun-Rhan
    Kang, Keon Wook
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (06) : 1097 - 1101
  • [35] Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma
    Ishikawa, Chie
    Senba, Masachika
    Mori, Naoki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (02) : 633 - 643
  • [36] A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation
    Hsin-Sheng Yang
    Aaron P Jansen
    Rajalakshmi Nair
    Keiichi Shibahara
    Ajit K Verma
    Joan L Cmarik
    Nancy H Colburn
    Oncogene, 2001, 20 : 669 - 676
  • [37] Active vitamin D inhibits osteoclastogenesis by interfering with AP-1/NF-κB activity in osteoclast precursors.
    Takasu, H
    Takeda, S
    Sugita, A
    Kake, T
    Kubota, N
    Ogata, E
    Ikeda, K
    Uchiyama, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S231 - S231
  • [38] Change of the Nuclear Protein Level of GR, AP-1 and NF-κB during the Glucocorticoid Treatment in Idiopathic Nephrotic Syndrome
    Sun, Li
    Ding, Xiao-Qiang
    Zhou, Jian-Zhou
    Teng, Jie
    Zhong, Yi-Hong
    Chen, Li-Ming
    Huan, Jing-Xing
    Fudan University Journal of Medical Sciences, 2003, 30 (05): : 418 - 421
  • [39] A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation
    Yang, HS
    Jansen, AP
    Nair, R
    Shibahara, K
    Verma, AK
    Cmarik, JL
    Colburn, NH
    ONCOGENE, 2001, 20 (06) : 669 - 676
  • [40] Association of NF-κB and AP-1 with MMP-9 Overexpression in 2-Chloroethanol Exposed Rat Astrocytes
    Wang, Tong
    Jin, Xiaoxia
    Liao, Yingjun
    Sun, Qi
    Luo, Chaohong
    Wang, Gaoyang
    Zhao, Fenghong
    Jin, Yaping
    CELLS, 2018, 7 (08)